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Abstract 
Central venous access devices play an important role in patients with prolonged intravenous 
administration requirements. However, these medical devices have shown to be susceptible to 
develop microbial infections with the associated risk of affecting the whole organism. In this 
sense, coating these devices with bactericidal compounds has emerged as a potential tool to 
prevent bacterial colonization. Our study describes the modification of 3D-printed reservoirs 
and silicone catheters, mimicking central venous access devices, through different approaches 
including their coating with the well-known biocompatible and bactericidal polymer chitosan, 
with the anionic polysaccharide alginate and also plasma treated surfaces were also included 
in the study to promote polymer adhesion. The evaluation of the antimicrobial action of those 
surface modifications compared to that exerted by a model antibiotic (ciprofloxacin) 
adsorbed on the surface of the devices was carried out. Surface characterization was 
developed by different methodologies and the bactericidal effects of the different coatings 
were assayed in an in vitro model of Staphylococcus aureus infection. Our results showed the 
great importance of the surface device topography for the successful attachment of the 
coating and for the subsequent development of bactericidal effects. Furthermore, the single 
presence of chitosan was enough to fully inhibit bacterial growth exerting a comparable 
efficiency as that showed by the model antibiotic though avoiding the potential emergence of 
antibiotic mediated resistances. Importantly, chitosan coating showed low cytotoxicity 
against human keratinocytes, human lung adenocarcinoma epithelial cells and murine colon 
carcinoma cells. Chitosan-based coatings are proposed as an effective and promising solution 
in the prevention of microbial infections associated to medical devices. 
 
Keywords: Central venous access devices, intravascular, bacterial infections, chitosan, 
antimicrobial 
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Introduction 
Central venous access devices (CVADs), also known as implantable ports, are of common 
use in the clinic and have become in a mainstay for patients who require prolonged 
intravenous drugs or nutrients administration.1,2 These devices consist of a catheter and a 
surgically implantable reservoir which are inserted in central veins providing long-term 
implantation unlike peripheral catheters.3 However, CVADs are prone to develop 
contamination resulting in chronic and nosocomial infections which can potentially be 
harmful due to their access to the whole organism through principal veins and may lead to 
major complications and to the associated high health-care burden.4 The site of insertion may 
initiate of microbial infection favoring the colonization of the catheter and the implanted 
reservoir.5 Furthermore, CVADs may be obstructed by thrombotic processes produced 
mainly inside or around the catheters, which can even impair their functionality.3,6 To solve 
these issues, coating the catheters with different materials such as Hydromer 
(polyvinylpyrrolidone) has been demonstrated as effective in the reduction of thrombosis and 
bacterial colonization.7,8  
Staphylococcus aureus has been reported to be present in different types of infected and 
noninfected wounds.9 Furthermore, it has been shown as highly prevalent and problematic in 
different wound infections, e.g. surgical wounds, recognizing its high incidence not only in 
wounds but also in nosocomial infections.9 Regarding medical devices, S. aureus may impair 
the functionality of implanted stents10 and plays an important role in the development of 
nosocomial infections of implants, catheters, devices, shunts, valves or prostheses.1 Its 
pathogenicity and its capacity to form biofilm represents an additional hurdle in the treatment 
of infections associated to medical devices.11 In this sense, it has been experimentally assayed 
both in vitro and in vivo as prevalent microorganism to mimic biofilm or nosocomial 
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infections12,13 or even when treating S. aureus infections with antibiotics as a model14,15 or 
with other compounds.16 
To avoid these infections, antibiotic prophylaxis has been shown as ineffective.17 This fact 
together with the possible generation of antibiotic resistance2,5 points towards the need of 
developing new approaches such as the use of bactericidal coatings on those devices to avoid 
microorganism colonization. 
The coating of catheters with different compounds such as cefazolin18, rifampicin19, silver10,20 
and chlorhexidine-silver sulfadiazine21 has been reported with similar efficiency against 
bacterial colonization though the potential development of antibiotic resistance impairs their 
antimicrobial capacity being more susceptible to develop infections than any antiseptic 
coating.21 In spite of the large antimicrobial action of silver, it has also been demonstrated its 
potential allergenic induction, cytotoxicity, induction of inflammation, apoptosis and DNA 
damage probably due to the release of silver ions22,23 together with the development of 
bacterial resistances.24,25 However, several commercial silver-coated catheters are being used 
in the clinical practice based on bio-inert silver-based zeolite (Vygon®) or on the galvanic 
effect mediated by the combination of silver, gold and palladium (Bactiguard®), though  
recent studies have shown no differences in the development of microorganisms growth in 
silver-coated and non-coated catheters obtained from catheterized patients.26 Furthermore, the 
coating of polydimethylsiloxane substrates with monomeric trimethylsilanes, including or not 
oxygen during the deposition procedure, has also been shown as an effective system to 
reduce the development of S. aureus associated infections both in vitro and in vivo.11 In this 
sense, the coating of the reservoir surface with biocompatible polymeric layers or films has 
emerged as an attractive approach.27 Another interesting surface modification, combining 
both chemical and physical modifications, is oxygen plasma treatment. In this process, a 
biomaterial surface in contact with plasma is bombarded with several species such as 
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electrons, photons, ions or free radicals, leading in consequence to surface cleaning, ablation 
and changes in the chemical composition of the substrate without altering its bulk 
properties.28 Moreover, the incorporation of oxygen containing functional groups, needed for 
drug or other polymer bonding, can be easily achieved after bombardment29 and this 
treatment can also reduce bacterial adhesion.28 This method has been successfully applied for 
the modification of polymeric surfaces.28,29 
In order to create an ideal biocompatible, anti-adhesive, anti-fouling and anti-infective 
surface on an implant, it is desirable to reduce bacterial adhesion by modifying the medical 
devices with bacteriostatic or antibacterial polymers such as chitosan (CS) or alginate 
(AG).29–32 CS is a polycationic aminopolysaccharide obtained by partial N-deacetylation of 
chitin, a natural biopolymer derived from crustacean shells, shrimps or other microorganisms 
such as fungi.33 In contrast to chitin, its derivative is soluble in most dilute acidic solutions at 
pHs below 6.5 due to the quaternisation of the amine groups with a pKa value of ~6.3.34 The 
protonation of these functional groups at pH below the pKa makes CS a water-soluble 
polyelectrolyte, which solubility strongly depends on the solvent pH. Another important 
parameter influencing the functional and physiological activity of CS is the average 
molecular weight (Mw).35 Depending on the polymer origin and the choice of the 
deacetylation process conditions, different deacetylation degrees and molecular weights can 
be obtained altering the resulting physicochemical and biological properties. In fact, 
moderate molecular weights and high deacetylation degrees have been shown higher 
bactericidal and anti-biofilm effects compared to low degrees and low Mw and oligomers36,37 
though the correlation between the CS Mw and its antimicrobial action is not clearly defined. 
Over the last decades, CS has attracted a huge interest, mainly due to its biocompatibility, 
biodegradability and antimicrobial activity.38,39 Its low toxicity profile combined with 
inertness have been proven by numerous in vitro and in vivo studies, reporting the lack of 
 6 
 
inflammatory or allergic reactions resulting from implantation, injection or topical 
application on the human body.40 CS exhibits a wide range of antibacterial and antifungal 
activity41 thus several antimicrobial CS-based products are commercially available39,42,43 
though the exact antimicrobial mechanism has not been fully elucidated yet. The most 
convincing hypothesis relates to the polycationic nature of CS and the resulting interactions 
between protonated amino groups and negatively charged components of microorganism cell 
walls, though the binding of CS to teichoic acids and the potential extraction of membrane 
lipids have also been proposed as potential mechanisms responsible for its pathogenicity.44 
Unlike CS, sodium AG is a negatively charged polysaccharide obtained from brown sea 
weed, readily soluble in water. Similarly to CS, sodium AG has gained a lot of attention due 
to its unique properties such as biocompatibility, biodegradability, non-toxicity and low 
cost.45 AG undergoes a mild gelation under the addition of divalent ions such as Ca2+, leading 
to hydrogel formation which can also be prepared by other cross-linking methods.46 Due to 
its features, it has been successfully used in tissue regeneration47 and drug delivery 
applications.48 Commercially available sodium alginates can vary in the molecular weight, 
which determines their physical properties. It is postulated that as the Mw increases, an 
improvement in the mechanical properties can be obtained, though the higher Mw, the higher 
viscosity and consequently its processability gets impaired.  
The present work proposes the use of dip coating techniques to coat 3D-printed reservoirs 
and silicone catheters with the bactericidal and biocompatible polymers CS and sodium AG, 
and with the model antibiotic, ciprofloxacin. In some cases an oxygen plasma treatment was 
also applied in order to increase the polymer or ciprofloxacin deposition and to reduce 
bacterial attachment. The antibacterial effectiveness of the different coatings assayed was 
investigated against S. aureus to elucidate the most suitable antimicrobial surface in order to 
avoid bacterial colonization of CVADs. 
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Materials and methods 
Chitosan, sodium alginate and ciprofloxacin hydrochloride solutions preparation 
Chitosan with medium average molecular weight (deacetylation degree (%) 89 ± 2; viscosity 
200-800 cP,1 wt. % in 1% acetic acid 25°C)49, sodium alginate and ciprofloxacin 
hydrochloride were purchased from Sigma Aldrich (Germany). Acetic acid (99.8%), used as 
a solvent, and sodium hydroxide were also supplied by Sigma Aldrich (Germany). All 
solutions were prepared in deionized water (MiliQ). 
CS stock solution (1% (w/v)) was prepared by dissolving polymer flakes in an aqueous 
solution of acetic acid (0.1 M). Heating (65°C) and mixing was maintained until a clear 
solution was obtained (around 12h). The pH of CS solution was ~4.5. Sodium AG 2% (w/v) 
solution was prepared in MiliQ water at room temperature. Ciprofloxacin hydrochloride was 
dissolved in MiliQ water and in the previously prepared 1% (w/v) CS solution to obtain the 
concentration of 100 µg/mL. The stability of the antibiotic in acidified polymer solution was 
monitored after several days by UV-Vis measurements. Sodium hydroxide 1% (w/v) aqueous 
solution was used for the neutralization of CS-coated scaffolds.  
Reservoirs and catheters 
The 3D design and printing of the reservoirs were developed with a 3D printer Objet Eden 
350V using a methacrylate derivative (proprietary composition) (Stratasys, US). The original 
CVAD and the autoCAD image used as model for the 3-D printer are shown in Figure 1. The 
silicone tubing, with the external diameter 4 mm, was purchased from MCZ (Poland). 
Catheters and 3D-printed scaffolds obtained are also presented in Figure 1. 
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Figure 1. CVAD design. (A) Original CVAD for clinical use (Port-A-Cath®, Smiths Group 
plc.). (B) CVAD 3D-design for our prototype. (C) CVAD prototype obtained from a 3D 
printer from top (left) and bottom (middle) views, and silicon catheter. 
Dip coating and characterization 
The dip coating technique consisted on the immersion of the catheters and reservoirs in the 
liquid coating medium (solubilized chitosan) followed by the evaporation of the solvent and 
the consequent deposition of the film on the surface of the catheters and reservoirs used as 
models.50 
The coating of the scaffolds with the polymers was performed with and without oxygen-
plasma treatment before dip-coating. A low pressure, low temperature plasma treatment was 
applied to remove the impurities and to generate oxygen-containing functional groups on the 
scaffolds surface. An enhancement in the polymer adhesion thanks to the presence of oxygen 
groups on the treated scaffold was expected.28,29 An oxygen flow (99.5%, Air Products) at a 
pressure of <0.3 mbar was introduced to the generator chamber. 100 W power and 40 Hz 
frequency were applied during the 30 s of the plasma treatment. In the experiment a Zepto 
plasma generator (Diener Electronic Plasma Technology, US) and a Dip Coater TLO.01 
(MTI Corporation, US) were used. The speed of the sample withdrawal from the solution was 
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1 cm/min. Silicone tubes and reservoirs were thoroughly cleaned with water and ethanol 
(Sigma Aldrich, 99.5% purity, Germany) and dried before coating. All of the scaffolds were 
weighed before and after coating in order to evaluate the weight gain. The number of group 
samples and coating protocols are presented in Scheme 1. Each group was composed of three 
samples to reach statistical significance. 
In each case, after dip coating with the corresponding polymer or antibiotic solution, samples 
were gently dried with a heat gun. In order to exclude any potential influence of the CS 
solvent (diluted acetic acid) on the antibacterial activity, two ways of neutralization were also 
conducted. 3D scaffolds and silicone tubes were submerged in 1% (w/v) sodium hydroxide 
solution and in deionized water (Scheme 1.11) after coating or the CS solution pH was 
adjusted to 5.73 (Scheme 1.12) before coating. 
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Scheme 1. Types of surface modifications on the CVADs prototypes and on the silicon tubes 
(CS = Chitosan; AG = Alginate; CP = Ciprofloxacin). 
 
 
 
 
The surface morphology of the reservoirs and tubes before and after coating was observed 
using scanning electron microscopy (SEM, Quanta FEG-250, FEI, US). The characterization 
of the surface roughness and waviness was carried out in a Kla-Tencor P6 Stylus Profiler 
(US). The chemical characterization of the surface before and after CS coating was 
performed by X-ray photoelectron spectroscopy (XPS) by using an Axis Ultra DLD (Kratos 
Analytical, UK). A monochromatic Al Kα X-ray radiation (hν = 1486.6 eV) was used as 
excitation source at 15 kV and 10 mA. The peaks analysis was developed by the CasaXPS 
software (Casa Software Ltd, UK). Fourier transform infrared spectroscopy (FTIR) was 
carried out to study surface infrared absorption of CS coated and uncoated reservoirs in a 
Bruker Vertex 70 (Bruker Corporation, US) equipped with a DTGS detector and ATR 
Golden Gate Diamond. The spectra were obtained with 4 cm-1 resolution in a range 4000-400 
cm-1. 
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In addition, the stability of ciprofloxacin hydrochloride in water and in CS acidified solution 
was evaluated by UV-Vis measurements (UV-Vis spectrophotometer Perkin Elmer, Lambda 
35, US) in order to check the chemical integrity of the molecule. 
In vitro infection model 
Staphylococcus aureus (BAControl, Ielab, Spain) was chosen as model bacteria due to its 
prevalence in device-associated infections as explained above. Lyophilized bacteria were 
reconstituted in tryptone soy broth (TSB) medium (Cultimed, Panreac, Spain) and further 
cultured overnight in the same medium at 37 ºC with agitation (150 rpm). 
Prior to the biological assays, reservoirs and catheters were sterilized by gas plasma 
(Sterilization facility, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain) to 
assure the adequate course of the infection model avoiding contaminations as well as 
catheters were cap-ended with stoppers to ensure that bacteria only contacted with the coated 
surfaces. 
The efficiency of the different coatings developed against infections (Scheme 1) was tested 
against an overnight S. aureus culture diluted to obtain 102 CFU/mL in fresh TSB medium. 
We selected this bacterial count rate because according to the clinical practice guidelines for 
the diagnosis and management of intravascular catheter-related infections, a bacterial count 
rate above 102 CFU/mL (determined from a catheter by quantitative (sonication) broth 
culture) reflects catheter colonization51. The reservoirs and catheters were independently 
placed in the bottom of sterilized bottles and the diluted bacteria culture added to a volume of 
40 mL in order to completely cover them. Samples were incubated overnight at 37 ºC with 
agitation (150 rpm). Then, samples aliquots collected from the bacteria culture were diluted 
in sterilized PBS and grown overnight on tryptone soy agar plates at 37 ºC. After incubation, 
S. aureus colonies were counted and the data expressed as CFU/mL standardized to the 
coating weight (mg). Control samples were also run to monitor the development of the 
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experiments. These control samples were a positive control sample in which a non-coated 
reservoir/catheter was incubated with S. aureus suspension to check normal bacteria 
colonization, a negative control consisting of a coated reservoir/catheter incubated in TSB 
without bacterial inoculum to check the adequate sterilization process, and different control 
samples without reservoir/catheter (TSB + S. aureus; TSB + Ciprofloxacin; TSB + S. aureus 
+ Ciprofloxacin) in order to test the methodology. Each group consisted of three independent 
samples and tests were performed in triplicate obtaining nine data per group to verify the 
reproducibility of the assays.  
In vitro cytotoxicity test 
Thiazolyl Blue Tetrazolium Bromide (MTT, 98%), Resazurin Sodium Salt (Alamar Blue), 
DMSO and methanol were supplied by Sigma Aldrich (Germany). Phosphate-Buffered 
Saline (PBS) without Ca2+ and Mg2+, fetal bovine serum (FBS), trypsin and antibiotics 
(Penicillin/Streptomycin/Amphotericin B Mix) were purchased from Pan Biotech (Germany). 
Dulbecco's Modified Eagle Medium (DMEM) with 4.5 g/L glucose, with L-Glutamine, 
sodium pyruvate and Phenol Red, supplied by Corning (US), was used in cell culturing. To 
determine the cytotoxic activity of the CS coatings, three different cell lines were used in this 
study: an immortal human keratinocyte (HaCaT), human lung adenocarcinoma epithelial cell 
line (A549) and murine colon cancer cell line (CT26). Cells were maintained in high-glucose 
DMEM with 1% of antibiotics and 10% of FBS. Cells were cultured at 37 °C in 5% CO2 
saturated air. Culture media were replaced every 2 days. Cells were passaged at least once a 
week.  
In vitro biocompatibility of the CS coatings was determined using material extracts.52 CS 
layers were prepared by pouring the CS solution into 12-well plates and drying in an electric 
oven at 60 °C for 3h followed by neutralization with 1 wt.% NaOH and deionized water. 
Before the experiment, chitosan layers were sterilized under UV light for 30 minutes. The 
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extracts were prepared as follows: each well with the chitosan layer was treated with 1.5 mL 
of cell culture medium without FBS and incubated for 24 h (37 °C, 5% CO2 atmosphere). 
Cells were seeded in 24-well flat bottom plates and also incubated for 24 h (37 °C, 5% CO2 
atmosphere) to obtain a final density of 7.5×104 cells/well. After 24 h the medium was 
replaced with the material extract at the concentration 100% or 50% when diluted with 
DMEM medium enriched with 10% FBS. Cells treated with DMEM without (S(-)) and with 
10% FBS (S(+)) were used as a positive control. After 24 h incubation cell viability was 
determined by the MTT and Alamar Blue assays53. Briefly, each well was rinsed with PBS 
and treated with 250 µL of the MTT solution (0.5 mg/mL) or Alamar Blue solution (25×10-6 
M) and incubated at 37°C for 3 h. In MTT assay, insoluble purple formazan crystals were 
dissolved in DMSO:CH3OH (1:1). The absorbance at 570 nm was measured in a microplate 
reader (Infinite 200 M PRO NanoQuant, Tecan) with a reference wavelenght at 670 nm. 
Results are presented as surviving cells fraction, [(A570nm of treated cells - A670)/(A570nm of 
untreated cells - A670]×100%, and expressed as mean values ± standard deviation. In the 
Alamar Blue assay, the fluorescence measurements were recorded with the λext at 560 nm and 
λem at 605 nm. Results are presented as surviving cells fraction and expressed as mean values 
± standard deviation. The results are the average values of three independent experiments. 
Statistical analyses 
Results are reported as mean ± SEM. Statistical study of data was performed using the 
StataSE 12 statistical software (StataCorp LP, US). The normal distribution of the variables 
was analyzed by the Shapiro Wilk test followed by ANOVA test, t-Student test or U-Man 
Whitney test. P ≤ 0.05 was considered to be statistically significant. 
Results and discussion 
Surface characterization 
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SEM micrographs of the surface of the uncoated reservoirs exhibit a differentiated 
topography (Figure 2). The coating of the scaffolds with polymers, both CS and CS/AG, 
significantly decreased the irregularity of the substrate and a smooth nanostructure resulted 
from the polymer presence was observed after coating. No significant differences between 
samples with and without plasma treatment were observed. SEM pictures of silicone tubes 
did not reveal any difference in the surface topography before and after coating with 
polymers irrespectively of the plasma treatment used (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. SEM micrographs of the 3D-printed reservoirs before (Control) and after coating 
with chitosan (CS – Group 1), chitosan and alginate (CS/AG – Group 3), chitosan after 
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plasma treatment (Plasma + CS – Group 2), chitosan and alginate after plasma treatment 
steps (Plasma + CS/ Plasma + AG  – Group 4). 
 
 
 
 
 
Figure 3. SEM micrographs of silicone tubes before (Control) and after coating with chitosan 
(CS– Group 1), chitosan and alginate (CS/AG – Group 3), chitosan after plasma treatment 
(Plasma + CS – Group 2), chitosan and alginate after plasma treatment steps (Plasma + CS/ 
Plasma + AG – Group 4). 
 
In order to further assess the nanostructure of the reservoirs and catheters before and after 
coating, their roughness profiles were also analyzed (Table 1). The surface length studied was 
500 µm in the case of the reservoirs and 200 µm for the catheters. These results pointed to a 
significant higher surface roughness of the uncoated reservoirs (control samples) than that 
obtained for the uncoated silicone tubes (control samples) being the reservoirs roughness a 
70% higher than that displayed for the catheters which might determine the coating 
adherence and efficiency and thus the subsequent bactericidal effects. After coating, 
reservoirs exerted a statistically significant reduction (58-73%) in surface roughness not 
finding statistically significant changes among the different coatings. However, catheters did 
not significantly vary their roughness values and no significant differences between coated 
and non-coated samples were found. 
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Table 1. Roughness profiles of the reservoirs and catheters before (Control) and after plasma 
treatment and CS and AG coating. The results are expressed as mean ± SD (nm) of at least 
three independent experiments 
 TREATMENT ROUGHNESS (nm) 
R
E
S
E
R
V
O
IR
S 
Control 25.0 ± 3.0 
CS 10.5 ± 2.5 
CS/AG 7.0 ± 1.7 
Plasma CS 9.5 ± 2.2 
Plasma CS/AG 8.8 ± 2.0 
C
A
T
H
E
T
E
R
S Control 7.5 ± 1.6 
CS 7.7 ± 1.7 
 
The determination of surface elemental concentrations for non-coated and CS coated 
reservoirs was performed by using XPS analysis (Table S1). The atomic composition of the 
reservoir surface showed that the CS coating increased the N/C ratio from 0.008 to 0.058 due 
to the N 1s atomic percentage increase from 0.7 at. % to 4.54 at. % after CS coating. This 
nitrogen increase is caused by the incorporation of primary amino groups from the chitosan 
backbone. The high resolution deconvolution of the N 1s peaks (data not shown) revealed a 
single peak at 400 eV for the control reservoirs indicative of the presence of R-CN groups 54. 
However, the CS coated reservoirs displayed two other peaks reducing the atomic percentage 
of R-CN in coated reservoirs until 18%. The new peaks found were R-NH2 (67%) and R-
NH3+ (15%), which clearly demonstrate the CS coating on the reservoirs.  
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To further characterize the reservoir surface regarding the interactions between the functional 
groups of the reservoir material and the CS, FTIR spectra of pure CS and reservoirs before 
and after CS coating were studied (Table S2). CS spectrum shows its characteristic bands at 
around 1640 cm-1 and 1590 cm-1 which is consistent with amide and amine groups, 
respectively 49. Uncoated reservoirs spectra show a band at 1725 cm-1 related to the stretching 
vibration of C=O groups 55, and bands at 1638 and 1450 cm-1 assigned to acrylate double 
bonds and distortion vibrations of CH2 respectively 56. After CS coating, the presence of a 
new band at 1568 cm-1, due to the asymmetric stretching of carboxylic groups, indicated the 
interaction of the CS amine groups with the carboxylic groups of the acrylonitrile present in 
the reservoirs57. These data evidenced the successful deposition of CS coating onto the 
reservoir through the reaction of the carboxylic groups of the reservoir acrylate and the CS 
amine groups. The XPS and FTIR spectra of the CS coated silicone tubes did not indicate the 
presence of the CS (data not shown). These results, together with the lack of surface 
roughness modification indicate that CS, under the tested conditions, did not adhere to the 
silicone tubes used as models. 
Finally, to test the stability of the model antibiotic assayed in the CS acidic solution, changes 
in the absorption spectra were also recorded. UV-Vis spectra of ciprofloxacin hydrochloride 
after dissolution in acidified chitosan did not show changes in comparison to distilled water at 
both time points (0 and 4 days) assayed (data not shown) indicative of the stability of the 
compound in acidic solutions. 
In vitro bacterial growth 
The measurement of the inhibition of S. aureus growth mediated by the coated scaffolds and 
catheters was evaluated by counting the number of CFU/mL obtained from the bacteria 
culture after overnight incubation in a 102 CFU/mL bacterial solution and further growth in 
agar plates. The results obtained for some of the scaffolds and catheters assayed are depicted 
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in Figure 4 and in Figure 5, respectively. It was found that for the reservoirs the presence of 
CS in the coating was enough to exert a significant and potent bactericidal effect and no S. 
aureus growth was displayed (Figure 4) which was corroborated after plating and counting. 
In fact, CS coatings on any of substrate modifications used were as efficient as ciprofloxacin 
adsorbed on the reservoirs which is a very relevant and notable data in a potential clinical 
application in order to avoid antibiotic-associated resistances. With this efficient bactericidal 
response exerted by the CS by itself no differences were observed when the substrate was 
previously treated with plasma, when it was re-coated with AG or even when it was 
embedded with CS and ciprofloxacin. In fact, the efficiency and homogeneity of the coating 
was corroborated due to the lack of bacterial growth along the device because any uncoated 
area would constitute a surface prone to bacterial colonization.  
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Figure 4. Scaffolds after treatment with S. aureus (102 CFU/ml). Positive and negative 
control samples are displayed in both pictures showing the bacteria growth in positive control 
as the CVAD was not coated and treated with the microorganism while the negative control 
was not treated with S. aureus showing that the sterilization process was successful for this 
type of materials. The experimental groups assayed did not show S. aureus growth due to the 
coating (chitosan, ciprofloxacin or chitosan+ciprofloxacin). The numbers of the samples in 
the pictures are referred to the group of samples explained in Scheme 1: group 1 was coated 
with chitosan, group 5 with ciprofloxacin and group 7 with a solution of both chitosan and 
ciprofloxacin. Group 11 and group 12 were first treated with plasma and coated with 
chitosan, but then chitosan coating in group 11 was neutralized, while group 12 coating was 
performed with a chitosan solution at a different pH (5.73).  
 
 
Figure 5 shows the biological results for the bare and CS coated silicone tubes. In those cases 
the counting of bacterial colonies in all the dilutions assayed have displayed a bacterial 
growth close to that observed for the control samples was obtained in all the experimental 
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groups studied. No statistically significant differences were observed among the control 
sample and the experimental groups. These results are in accordance with the XPS, FTIR and 
surface roughness data where the lack of an appropriated adherence between the CS and the 
silicone tubes was demonstrated. These results clearly show the paramount importance of the 
CVAD material in order to adhere and retain the coating on the surface of the device and so 
to achieve an efficient bactericidal action. The nature and roughness of the material used as 
substrate is crucial to obtain an adequate and functional coating against potential infections. 
The coating of CVADs has emerged as a potential tool in the biomedical field to minimize or 
even impair infections. These coatings are intended to solve the emergence and spread of 
nosocomial or chronic infections mainly initiated in the insertion site, based on different 
compounds such antibiotics or silver 58,10,11,18–21,32,59,60. A recent work11 has described the 
surface modification of silicone rubber surfaces through a nanoscale plasma methodology 
using monomeric trimethylsilane and oxygen showing a significant inhibition of S. aureus 
biofilm formation in vitro which was dependent on the oxygen deposition ratio. The posterior 
in vivo study also revealed the efficiency of these devices in an infection model, mediated by 
the inoculation of S. aureus (108 CFU), though a total reduction in the bacterial growth was 
not observed. The chemical immobilization of an antimicrobial peptide on the surface of gold 
nanoparticles has been successfully tested fully inhibiting S. aureus growth which could be 
translated onto other types of surfaces and medical devices59 though it is not so cost-effective 
and technologically affordable as CS. A nanostructured silver coating on 
polydimethylsiloxane surfaces deposited by using plasma enhanced chemical vapor 
deposition has been shown to fully diminish S. aureus viability without a significant decrease 
in COS-7 cell viability though linked to Ag+ release10 which has been previously shown as 
potentially harmful23. 
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CS has been widely shown as an effective in vitro bactericidal polymer against S. aureus38 
displaying high biocompatibility on human cells. Our group has previously synthesized 
nanocomposites based on solid CS-gold-nanoparticle films exerting a total bactericidal effect 
in an in vitro infection model of S. aureus and P. aeruginosa at CS concentrations and Mws 
close to those described in this work, not showing cytotoxic effects against HaCaT and A549 
cell lines61. Furthermore, the antibacterial effect of CS against other bacteria strains such as 
Escherichia coli has also been reported32,60. The deposition of CS alternatively with heparin 
onto aminolyzed poly(ethylene terephthalate) films to obtain bactericidal multilayer films 
showed a high efficiency after 24h exerting a bacteria viability lower than 8% when 5×104 
CFU/ml were inoculated onto the multilayer surface. Interestingly, this effect was found to be 
dependent on the pH used during the assembly showing a higher efficiency at lower pH due 
to the changes in the degree of ionization of amino groups and CS, effect that was not 
revealed in our studies. In addition, these authors highlighted that this pH dependency is 
linked to the amount of CS deposited on the outer layer because most CS chains were 
observed at lower pH32. Moreover, the antibacterial activity of multifunctional composite 
coatings based on bioactive glasses and CS against E. coli was investigated in different 
surfaces60. Though both bioactive glass and CS have demonstrated antibacterial properties, 
the composite coatings assayed exerted lower bactericidal effects than pure CS which was 
attributed to the differences in the surface roughness as it has been highlighted in our study.  
Some studies assessed the bactericidal mechanism by which CS is able to eradicate bacteria. 
The interaction with the negatively charged bacterial wall and/or membrane collapsing its 
functionality and inducing the cytoplasm components leakage62 is one of the proposed 
mechanisms of the biocidal action though other authors have pointed to CS nuclear mediated 
damage38 or even the chelation of trace metals and the consequent disruption of the 
enzymatic activity63.  
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The coating of CVADs with an efficient antimicrobial agent and non-toxic against human 
cells as CS makes this polymer a potential candidate for further applications in the prevention 
of chronic and nosocomial infections associated to medical devices. 
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Figure 5. Silicon catheters (A, B) and colony forming units per mL (CFU/mL) (C) obtained 
after treatment with S. aureus (102 CFU/ml). Positive and negative controls are shown (A, B). 
S. aureus grew in positive control due to the lack of coating and the treatment with the 
microorganism while the negative control was not treated with S. aureus showing that the 
sterilization process was successful for this type of materials. All the experimental groups 
displayed bacteria growth. The numbers of the samples in the pictures are referred to the 
group of samples explained in Scheme 1: group 1 was coated with chitosan, group 5 with 
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ciprofloxacin and group 7 with a solution of both chitosan and ciprofloxacin. Group 11 and 
group 12 were first treated with plasma and coated with chitosan, but then chitosan coating in 
group 11 was neutralized, while group 12 coating was performed with a chitosan solution at a 
different pH (5.73).  
 
 
In vitro biocompatibility tests 
The in vitro cytotoxic effect of CS layers on HaCaT, A549 and CT26 cell lines was 
determined using extracts of materials. MTT and Alamar Blue assay performed using extracts 
with and without serum proteins revealed no cytotoxic effects (Figure 6). There was no 
statistical difference between the viability values after incubation with extracts with or 
without FBS. CS layers meet the requirement of the ISO 10993-5 norm (Biological 
evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity), which considers 
materials as non-cytotoxic when the cell viability is higher than 70%. 
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Figure 6. The cytotoxicity test results for the CS coatings towards three cell lines: human 
keratinocytes (HaCaT), human lung adenocarcinoma epithelial cell line (A549) and murine 
colon carcinoma cells (CT26). The red line marks the 100% cell viability which responds to 
the positive control (cells cultured in medium without sample). (S(-) and S(+) stands for 
medium without and with serum proteins respectively upon the experiment performance). 
 
Conclusions 
CS coatings were successfully tested in 3D-printed reservoirs mimicking CVADs as powerful 
antimicrobial agents to avoid the development and spread of S. aureus infection showing high 
biocompatibility and low cytotoxicity. Our study indicated that the single presence of CS is 
enough to halt the infection being highly relevant the surface material regarding composition 
and roughness to obtain an efficient coating and thus the highest bactericidal activity. The 
addition of AG and/or plasma treatment did not improve the coating bactericidal efficiency as 
CS alone displayed a total bactericidal activity showing the same efficiency as the model 
antibiotic assayed. This work reveals the paramount importance of CS in the prevention of 
microbial colonization of CVADs underlining its potential as bactericidal agent in biomedical 
applications, though further studies regarding its hemostatic properties should be performed 
in order to fully understand its suitability for intravascular applications. 
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